DeSoto, TX, September 16, 2015 --(PR.com
)-- Crosetto’s breakthrough invention has the highest life-saving potential through effective early detection of cancer. This is achievable by funding the fabrication of an integrated circuit used in his 3D-CBS device that contains the electronic circuits that he developed and tested in a board in 2003. The gain in this conversion, from 64x 3D-Flow processors in a board to 64x 3D-Flow processors in a chip, will allow him to build a 3D-Flow system, which is more than 13 times faster at 0.5% of the cost and one-tenth of the power consumption.
Crosetto’s 3D-CBS invention extracts all valuable information from radiation, resulting in an improvement hundreds of times better than the performance of current medical imaging devices and therefore providing for earlier detection, accurate prognosis and efficient monitoring of treatment. This is achieved due to synergy between economical detectors and advanced electronics made from 14,400 x 3D-Flow processors and by balancing the number of communication wires between chips and boards with speed to produce the most cost-effective performance.
About the Inventor:
Crosetto is the founder and president of the Crosetto Foundation for the Reduction of Cancer Deaths and the inventor of 3-D Complete Body Screening (3D-CBS) technology. This technology is based on the 3D-Flow architecture that he invented for the discovery of new particles when doing research at the Superconducting Super Collider, in Texas, and using his 20 plus years of experience on CERN experiments, in Geneva, solving the challenging problem of extracting all valuable information from radiation data that could not be stored due to its immense quantity.
Crosetto asserts that the economic burden of cancer would be reduced if funding agencies were forced to estimate the reduction of cancer deaths that would likely be achieved by their research and present a plan for testing it in the community.
Early Detection leads to Effective Treatment
“For over 70 years now, experimental data has demonstrated that early detection can save 50% of lives,” says Crosetto. “The next step should be to observe the signals at the anatomical and chemical level generated when normal cells mutate to cancerous cells. Metabolism is one of the most reliable signals observed at cancer mutation’s earliest stage and when confirmed with anatomical changes such as tissue density and others changes, provides physicians with excellent information for an accurate diagnosis. Both metabolism and tissue density are signals detected by medical imaging devices (PET/CT) using radiation.”
Crosetto’s 3D-CBS technology is an advanced PET/CT. The breakthrough advantages of the 3D-Flow invention used in the 3D-CBS device have been recognized by major public scientific reviews and have been demonstrated feasible and functional in hardware. Additionally, the technology opens the door to further biomedical research by providing accurate information about minimum abnormal biological processes that could be used for prognosis and treatment of many other diseases.
“This staggering improvement in efficiency enables safe and cost-effective early detection with the potential to save over 50% of the seven million cancer sufferers who face death annually,” says Crosetto. “There are some doctors and journalists who claim early detection can result in unnecessary procedures. No one is perfect and human error can always occur; however, we should not abandon a technology that can save millions of lives because of a few false positives. Better training for medical personnel should help avoid this.”
How you can Contribute:
Advocacy - Reach out to your political representatives to encourage bipartisan commitment for transparency in funding cancer research. Share this press release. Reach out to funding agencies that are using taxpayer and donation money and ask for transparency in science.
Funding - Contribute to support this vision of transparency in cancer research by making a tax-deductible donation to Crosetto Foundation for the Reduction of Cancer Deaths
, a U.S., 501(c)(3), tax-exempt and not-for-profit organization.
“What is needed to unveil the scientific truth is a public debate among scientists who claim highest reduction in cancer deaths and cost before funding agencies assign money to scientists who have less efficient, more costly approaches.”